Correlation Between CytomX Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on CytomX Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Tempest Therapeutics.
Diversification Opportunities for CytomX Therapeutics and Tempest Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CytomX and Tempest is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Tempest Therapeutics
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 0.87 times more return on investment than Tempest Therapeutics. However, CytomX Therapeutics is 1.15 times less risky than Tempest Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 101.00 in CytomX Therapeutics on August 28, 2024 and sell it today you would lose (5.00) from holding CytomX Therapeutics or give up 4.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Tempest Therapeutics
Performance |
| Timeline |
| CytomX Therapeutics |
| Tempest Therapeutics |
CytomX Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite CytomX Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. HCW Biologics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |